Article information
Full text is only aviable in PDF
Bibliografía
[1.]
R. Peto, A.D. López, J. Boreham, M. Thun, C. Heath.
Mortality from tobaceo in developed countries: indirect estimation from national vital statistics.
Lancet, 339 (1992), pp. 1.268-1.278
[2.]
N.R. Anthonisen, J.E. Connett, J.P. Kiley, M.D. Altose, W.C. Bailey, et al.
Effect of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV, The Lung Health Study.
JAMA, 272 (1994), pp. 1.497-1.505
[3.]
scdssa.
Indicadores de salud.
información sanitaria y epidemiológica, Ministerio de Sanidad y Consumo, (1990),
[4.]
S.L. Parker, T. Tong, S. Bolden, P.A. Wingo.
Cancer statistics, (1996), pp. 34-36
[5.]
R.J. Ginsberg, M.G. Kris, J.G. Armstrong.
Cancer of the lung.
Cancer: principies and practice of oncology, 4.ª, pp. 673-722
[6.]
Smoking, Health.
A physician responsability. A statement of the Joint Committee on Smoking and Health, 8 (1995), pp. 808-811
[7.]
J. Prochazka, C.C. Diclemente.
Stages and processes of self change of smoking: toward an integrative model of change.
J Consult Clin Psychology, 51 (1983), pp. 390-395
[8.]
J. Prochazka, C.C. Diclemente, W. Velicer.
Predicting change in smoking status for self changers.
Addict Behav, 10 (1985), pp. 395-406
[9.]
C.A. Jiménez Ruiz, J.M. González de Vega, C. Escudero, A. García, J. Roca, S. Solano, et al.
Tabaquismo.
Manuales SEPAR, (1995), pp. 1-109
[10.]
C. Orleans, L. Gerorge, J. Houpt.
Health promotion in primary care: a survey of US family practitioners.
Prevent Med, 14 (1985), pp. 636-647
[11.]
J.K. Ockene.
Physician-delivered interventions for smoking cessation: strategies for increasing effectiveness.
Prevent Med, 16 (1987), pp. 723-737
[12.]
G. Marlatt, J. Gordon.
Relapse prevention: maintenance strategies in the treatment of adictive behaviours.
Guilford Press, (1985),
[13.]
T. Glynn, M. Manley.
How to help your patients stop smoking? National cancer Institute. Manual for physicians (NIH publication N.“ 90-3064). Bethesda. Smoking.
Tobacco and Cancer Program. Division of cancer prevention and control, National Cáncer Institute, (1989),
[14.]
J.A. Stapleton, M.A.H. Russell, C. Feyerabend, S.M. Wiseman, G. Gustavsson, U. Sawe, et al.
Dose effects and predictors of outcome in a randomizet trial of transdermal nicotine patches in general practice.
Addiclion, 90 (1995), pp. 31-42
[15.]
T. Kottke, R. Battiste, G. DeFriese, M.L. Brekkg.
Attitudes of successful smoking cessation intervention in medical practice: a metaanalysis of 39 controlled trials.
JAMA, 259 (1988), pp. 2.883-2.889
[16.]
Research Committee of the British Thoracic Society.
Smoking cessation in patients: two futher studies by the British Thoracic Society.
Thorax, 45 (1990), pp. 835-840
[17.]
P. Tønnesen.
Smoking cessation programs.
Lung cancer., pp. 75-89
[18.]
M.A.H. Russell, C. Wilson, C. Taylor, C.D. Baker.
Effect of general practitioners advice against smoking.
BMJ, 2 (1979), pp. 231-235
[19.]
P. Stewart, W.W. Rosser.
The impact of routine advice on smoking cessation from family physicians.
Can Med Assoc J, 126 (1982), pp. 1.051-1.054
[20.]
F. Jamrozik, G. Fowler, M. Vessey.
Controlled trial of three different antismoking interventions in general practice.
BMJ, 288 (1984), pp. 1.499-1.503
[21.]
K. Slama, S. Karsenty, A. Hirsh.
Effectiveness of minimal intervention by general practitioners with their smoking patients: a randomised, controlled trial in France.
Tobacco Control, 4 (1995), pp. 162-169
[22.]
P. Tønnesen, C. Mikkelsen, A. Markholst, A. Ibsen, M. Bendixen, L. Pedersen, et al.
Nurse-conducted smoking cessation with minimal intervention in a lung clinic: a randomized controlled study.
Eur Respir J, 9 (1996), pp. 2.351-2.355
[23.]
C.A. Jiménez Ruiz, M. Barrueco Ferrero, F. Carrión Valero, R. Cordovilla, I. Hernández, E. Martínez Moragón, et al.
Intervención mínima personalizada en el tratamiento del tabaquismo.
Resultados de un estudio multicéntrico. Arch Bronconeumol, 34 (1998), pp. 433-436
[24.]
US., Department of Health, Human Services.
The health consequences of smoking: chronic obstructive lung disease. A Report of the Surgeon General.
US Department of Health and Human Services. Office on Smoking and Health, US Government Printing office, (1984),
[25.]
S.R. Cummings, S.M. Rubin, G. Oster.
The Cost-effectiveness of counseling smokers to quit.
JAMA, 251 (1989), pp. 75-79
[26.]
R.F. Anda, P.L. Remington, D.G. Sienko, R.M. Davis.
Are physicians advising smokers to quit?.
The patient's perspective. JAMA, 257 (1987), pp. 1.916-1.919
[27.]
F. Carrión Valero, F. Furest.
¿Se realiza intervención mínima en tabaquismo en nuestro país?.
Arch Bronconeumol, 1 (1995), pp. 24
[28.]
P. Hajek.
What “behavioural supplement” is neccesary for nicotine replacement to work?.
Future Directions in Nicotine Replacement Therapy, (1993), pp. 28
[29.]
K.O. Fagerström, N.G. Schneider.
Measuring nicotine dependence: a review of the Fagerström tolerance nicotine questionnaire.
J Behav Med, 12 (1989), pp. 159-182
[30.]
U.S., Department of Health, Human Services.
The health consequences of smoking: nicotine addiction..
A report of the Surgeon General, US Government Printing office, (1988),
[31.]
R.C. Klesges, A.W. Meyers, S.E. Winders, S.N. French.
Determining the reasons for weight gain following smoking cessation: Current findings, methodological issues and future directions for research.
Ann Behav Med, 11 (1989), pp. 134-143
[32.]
L.A. Kuck.
Weight Management: a special problem for smoking cessation among women.
Sem Res Cr C Med, 16 (1995), pp. 104-110
[33.]
K.A. Perkins.
Weight gain following smoking cessation.
J Consult Clin Psychol, 61 (1993), pp. 768-777
[34.]
K.O. Fagerström.
Reducing the weight gain after stopping smoking.
Addict Behav, 12 (1987), pp. 91-93
[35.]
N. Schneider.
Nicotine therapy in smoking cessation.
Pharmacokinetic considerations. Clin Pharmacokinet, 23 (1992), pp. 169-172
[36.]
N. Benowitz.
Pharmacological aspects of cigarettes smoking and nicotine addiction.
N Engl J Med, 319 (1988), pp. 1.318-1.330
[37.]
C.A. Jiménez Ruiz, S. Solano.
Tratamiento del tabaquismo.
Terapia sustitutiva con nicotina. Rev Clin Esp, 194 (1994), pp. 487-491
[38.]
K.O. Fagerström.
Effects of nicotine chewing gum and follow-up appointments in physician based smoking cessation.
Prevent Med, 13 (1984), pp. 517-527
[39.]
P. Tønnesen, V. Fryd, M. Hansen, J. Helsted, A.B. Gunnersen, H. Forchammer, et al.
Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking.
N Engl J Med, 318 (1988), pp. 15-18
[40.]
P. Tønnesen, V. Fryd, M. Hansen, et al.
Two and four mg nicotine chewing gum and group counseling in smoking cessation: an open, randomized, controlled trial with a 22 month follow up.
Addict Behav, 13 (1988), pp. 17-27
[41.]
T. Abelin, A. Buehler, P. Müller, K. Vesanen, P. Imhof.
Controlled trial of transdermal nicotine patch in tobacco withdrawal.
Lancet, 1 (1989), pp. 7-10
[42.]
P. Tønnesen, J. Nørregaard, K. Simonsen, U. Sawe.
A double blind trial of a 16-hour transdermal nicotine patch in smoking cessation.
N Engl J Med, 325 (1991), pp. 311-315
[43.]
Transdermal Nicotine Study Group.
Transdermal nicotine for smoking cessation: six month results from two multicenter controlled clinical trials.
JAMA, 266 (1991), pp. 3.133-3.138
[44.]
M.C. Fiore, D.E. Jorenby, T. Baker, S.L. Kenfor.
Tobacco dependence and the nicotine patch, clinical guidelines for effective use.
JAMA, 268 (1992), pp. 2.687-2.694
[45.]
D.M. Daughton, S.A. Heatley, J.J. Prendergast, D. Causey, M. Knowles, C.N. Rolf, et al.
Effect of transdermal nicotine delivery as an adjunt to low intervention smoking cessation therapy: a randomized, placcbo-controlled double-blind study.
Arch Intern Med, 151 (1991), pp. 749-752
[46.]
Collaborative European Anti-Smoking Evaluation Study.
European Respiratory Annual Congress.
Estocolmo, septiembre de, (1996),
[47.]
C. Silagy, D. Mant, G. Fowler, M. Lodge.
Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation.
Lancet, 343 (1994), pp. 139-142
[48.]
G. Sutherland, J. Stapleton, M.A.H. Russell, M. Jarvis, P. Hajek, M. Belcher, et al.
Randomized controlled trial of nasal nicotine spray in smoking cessation.
Lancet, 340 (1992), pp. 324-329
[49.]
P. Tønnesen, J. Norregaard, K. Mikkelsen, S. Jorgensen, F. Nilsson.
A double-blind trial of a nicotine inhaler for smoking cessation.
JAMA, 269 (1993), pp. 1.268-1.271
[50.]
M. Kornitzer, M. Boutsen, M. Dramaix, J. Thijs, G. Gustavsson.
Combined use of nicotine patch and gum in smoking cessation. A placebo-controlled clinical trial.
Prevent Med, 24 (1995), pp. 41-47
[51.]
J. Hughes, M. Cummings, A. Hyland.
Ability of smokers to reduce their smoking and its association with future smoking cessation.
Addiction, 94 (1999), pp. 109-114
[52.]
D. Sachs, N. Benowitz.
Individualizing medical treatment for tobacco dependence.
Eur Respir J, 9 (1996), pp. 629-631
[53.]
P. Paoletti, E. Fornai, F. Maggiorelli, R. Puntoni, G. Viegi, L. Carrozzi, et al.
Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch.
Eur Respir J, 9 (1996), pp. 643-651
[54.]
E. Monsó.
Los parches de nicotina.
¿Son realmente útiles?. Arch Bronconeumol, 32 (1996), pp. 435-436
[55.]
P. Tønnesen, P. Paoletti, G. Gustavsson, M.A. Russell, R. Saracci, A. Gulsvik, members of the Steering Committe of CEASE on behalj of the European Respiratory Society, et al.
Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial.
Eur Respir J., 13 (1999), pp. 238-246
[56.]
N. Schneider, E. Lunell, R.E. Olmstead, K.O. Fagerström.
Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.
Clin Pharmacokinet, 31 (1996), pp. 65-80
[57.]
A. Hjalmarson, M. Franzon, A. Westin, O. Wiklund.
Effect of nicotine nasal spray on smoking cessation: a randomised. placebo-controlled, double-blind study.
Arch Intern Med, 154 (1994), pp. 2.567-2.572
[58.]
N.G. Schneider, R. Olmstead, F.V. Mody, K. Doan, M. Frauzon, M. Jarvik, et al.
Efficieney of a nicotine nasal spray in smoking cessation: a placebo controlled, double-blind trial.
Addiction, 90 (1995), pp. 1.671-1.682
[59.]
T. Blöndal, M. Franzon, A. Westin.
A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation.
Eur Respir J, 10 (1997), pp. 1.585-1.590
[60.]
T. Blondal, L. Gudmundsson, I. Olafsdottir, G. Gustausson, A. Westin.
Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.
BMJ, 318 (1999), pp. 285-288
[61.]
J.L. Tang, M. Law, N. Wald.
How effective is nicotine replacement therapy in helping people to stop smoking?.
BMJ, 308 (1994), pp. 21-26
[62.]
S.L. Kenford, M.C. Fiore, D.E. Jorenby, S. Smith, D. Wetter, T.B. Baker.
Predicting smoking cessation: who will quit with and without the nicotine patch.
JAMA, 271 (1994), pp. 589-594
[63.]
D.E. Jorenby, S.S. Smith, M. Fiore, R. Hurt, K.P. Offord, I.T. Croghan, et al.
Varying nicotine patch dose and type of smoking cessation counseling.
JAMA, 274 (1995), pp. 1.347-1.352
[64.]
L.C. Dale, R. Hurt, K.P. Offord, G.M. Lawson, I.T. Croghan, D.R. Schroeder.
High-dose nicotine patch therapy.
Percentage of replacement and smoking cessation. JAMA, 274 (1995), pp. 1.353-1.358
[65.]
R.M. Glass.
Blue mood, blackened lungs: depresion and smoking.
JAMA, 264 (1990), pp. 1.583-1.584
[66.]
S.M. Hall, R. Muñoz, V. Reus.
Smoking cessation. depresion and dysphoria. NIDA Res.
Monogr., 105 (1991), pp. 312-313
[67.]
J.A. Ascher, J.O. Cole, J.P. Feighner, R.M. Ferris, H.C. Fibiger, R.N. Golden, et al.
Bupropion: a review of its mechanism of antidepressant activity.
J Clin Psychiatry, 56 (1995), pp. 395-401
[68.]
R. Hurt, D. Sachs, E. Glovcr, K. Offord, J. Johnston, L. Dale, et al.
A comparison of instained-relaise bupropion and placebo for smoking cessation.
N Engl J Med, 337 (1997), pp. 1.195-1.202
[69.]
D.E. Jorenby, S.J. Leischow, M.A. Nides, S.T. Rennard, J.A. Johnston, A.R. Hughes, et al.
A controlled trial of sustained released bupropion. a nicotine patch, or both for smoking cessation.
N Engl J Med, 340 (1999), pp. 685-691
C.A. Jiménez Ruiz (Madrid), S. Solano Reina (Madrid), J.M. González de Vega (Granada), M.J. Ruiz Pardo (Barcelona), S. Flórez Martín (Madrid), A. Ramos Pinedo (Ciudad Real), M. Barrueco Ferrero (Salamanca) y F. Carrión Valero (Valencia).
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
